Intercept Pharmaceuticals Stock Price, News & Analysis

ICPT NASDAQ

Company Description

Intercept Pharmaceuticals (NASDAQ: ICPT) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

ICPT stock has declined 100.0% over the past year.

This page provides a comprehensive overview of ICPT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

41.8M

Shares outstanding

Intercept Pharmaceuticals (ICPT) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

May 9, 2024

0.00%

Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference

February 29, 2024

0.00%

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

clinical trial fda approval

November 13, 2023

0.00%

Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023

clinical trial

November 10, 2023

0.00%

Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023

November 8, 2023

0.00%

Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.

acquisition

November 8, 2023

0.00%

Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include clinical trial, fda approval, acquisition, management. View all ICPT news →

SEC Filings

View All

No SEC filings available for ICPT.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ICPT Company Profile & Sector Positioning

Intercept Pharmaceuticals (ICPT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.